Tissue effects of a newly developed diode pumped pulsed Thulium:YAG laser compared to continuous wave Thulium:YAG and pulsed Holmium:YAG laser.

Continuous wave Thulium:YAG laser (CW) Holmium:YAG laser Pulsed Thulium:YAG laser Tissue interaction

Journal

World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 07 10 2020
accepted: 05 02 2021
pubmed: 18 3 2021
medline: 29 1 2022
entrez: 17 3 2021
Statut: ppublish

Résumé

The objective of this study is to evaluate the laser-tissue effects of laser radiation emitted by a newly developed high frequency pulsed Tm:YAG laser in comparison to the continuous wave Tm:YAG laser and the pulsed Ho:YAG laser. Ex-vivo experiments were performed on freshly slaughtered porcine kidneys in a physiological saline solution. Experiments were performed using two different laser devices in different settings: A Tm:YAG laser was operated in a pulsed mode up to 300 Hz and in a continuous wave (CW) mode. Results were compared with a 100 W standard pulsed Ho:YAG laser system. Comparative tissue experiments were performed at 5 W, 40 W and 80 W. The incision depth and the laser damage zone were measured under a microscope using a calibrated ocular scale. Increased laser power resulted in increased incision depth and increased laser damage zone for all investigated lasers in this set-up. The Ho:YAG created the largest combined tissue effect at the 5 W power setting and seems to be the least controllable laser at low power for soft tissue incisions. The CW Tm:YAG did not incise at all at 5 W, but created the largest laser damage zone. For the new pulsed Tm:YAG laser the tissue effect grew evenly with increasing power. Among the investigated laser systems in this setting the pulsed Tm:YAG laser shows the most controllable behavior, insofar as both the incision depth and the laser damage zone increase evenly with increasing laser power.

Identifiants

pubmed: 33728503
doi: 10.1007/s00345-021-03634-4
pii: 10.1007/s00345-021-03634-4
pmc: PMC8510916
doi:

Substances chimiques

Thulium 8RKC5ATI4P

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3503-3508

Informations de copyright

© 2021. The Author(s).

Références

Br J Urol. 1988 Jun;61(6):487-9
pubmed: 2900041
BJU Int. 2010 Aug;106(3):368-72
pubmed: 19912204
Springerplus. 2016 Mar 03;5:266
pubmed: 27006875
Curr Opin Urol. 1998 Jan;8(1):11-5
pubmed: 17035836
Chin Med J (Engl). 2015 Apr 5;128(7):884-9
pubmed: 25836607
BJU Int. 2011 Apr;107(7):1030-43
pubmed: 21438974
Lasers Surg Med. 2010 Mar;42(3):237-44
pubmed: 20333741
Urology. 2012 Apr;79(4):869-74
pubmed: 22342411
Eur Urol. 2015 Jun;67(6):1099-1109
pubmed: 25613154
Eur Urol. 2016 Mar;69(3):475-82
pubmed: 26344917
Urol Clin North Am. 1988 Aug;15(3):369-75
pubmed: 2900567
Actas Urol Esp. 2013 Feb;37(2):63-78
pubmed: 22989380
Urology. 1996 Jan;47(1):48-51
pubmed: 8560662
Lasers Med Sci. 2009 Mar;24(2):172-8
pubmed: 18270761
J Endourol. 1994 Apr;8(2):105-10
pubmed: 8061665
Br J Urol. 1992 Jun;69(6):603-8
pubmed: 1379101

Auteurs

Stephan Huusmann (S)

Department of Urology and Urologic Oncology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. huusmann.stephan@mh-hannover.de.

Marcel Lafos (M)

Hannover Medical School, Institute for Pathology, Hannover, Germany.

Ingo Meyenburg (I)

LISA Laser Products GmbH, Katlenburg-Lindau, Germany.

Rolf Muschter (R)

Alta Clinic, Bielefeld, Germany.

Heinrich-Otto Teichmann (HO)

LISA Laser Products GmbH, Katlenburg-Lindau, Germany.

Thomas Herrmann (T)

Clinic for Urology, Spital Thurgau, Thurgau, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH